- 全部删除
您的购物车当前为空
JNJ-9676是一种具有口服活性的冠状病毒膜蛋白抑制剂,通过膜蛋白二聚体跨膜结构域形成的结合口袋,从而阻断病毒组装与释放,对新冠病毒和SARS-CoV具有纳米摩尔水平的抗病毒活性。


为众多的药物研发团队赋能,
让新药发现更简单!
JNJ-9676是一种具有口服活性的冠状病毒膜蛋白抑制剂,通过膜蛋白二聚体跨膜结构域形成的结合口袋,从而阻断病毒组装与释放,对新冠病毒和SARS-CoV具有纳米摩尔水平的抗病毒活性。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,420 | In stock | |
| 5 mg | ¥ 3,130 | In stock | |
| 10 mg | ¥ 4,480 | In stock | |
| 25 mg | ¥ 6,960 | In stock | |
| 50 mg | ¥ 9,390 | In stock | |
| 100 mg | ¥ 12,600 | In stock | |
| 200 mg | ¥ 16,800 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 3,430 | In stock |
JNJ-9676 相关产品
| 产品描述 | JNJ-9676 is an orally active inhibitor of the coronavirus membrane protein, which binds to the membrane protein dimer's transmembrane domain-formed binding pocket, thereby blocking viral assembly and release. It exhibits nanomolar-level antiviral activity against the novel coronavirus and SARS-CoV. |
| 别名 | JNJ9676 |
| 分子量 | 497.5 |
| 分子式 | C28H21F2N5O2 |
| CAS No. | 3026520-19-1 |
| Smiles | C(NC1=CC(C#N)=CC=C1)(=O)C2=C3N(C[C@H](C)N(C3=O)C4=CC=C(C(F)(F)C5=CC=CC=C5)C=C4)N=C2 |
| 密度 | no data available |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 180 mg/mL (361.81 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容